These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7807185)

  • 41. Antitumour activity of a sterically blocked ricin immunotoxin on a human colorectal adenocarcinoma grafted subcutaneously in nude mice.
    Brusa P; Dosio F; Pietribiasi F; Delprino L; Feraiorni P; Mariani M; Bussolati G; Cattel L
    Cancer Immunol Immunother; 1992; 35(6):373-80. PubMed ID: 1394342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer.
    FitzGerald DJ; Bjorn MJ; Ferris RJ; Winkelhake JL; Frankel AE; Hamilton TC; Ozols RF; Willingham MC; Pastan I
    Cancer Res; 1987 Mar; 47(5):1407-10. PubMed ID: 3493065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uptake of native and deglycosylated ricin A-chain immunotoxins by mouse liver parenchymal and non-parenchymal cells in vitro and in vivo.
    Blakey DC; Skilleter DN; Price RJ; Thorpe PE
    Biochim Biophys Acta; 1988 Feb; 968(2):172-8. PubMed ID: 3257705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An immunotoxin cytotoxic for breast cancer cells in vitro.
    LeMaistre CF; Edwards DP; Krolick KA; McGuire WL
    Cancer Res; 1987 Feb; 47(3):730-4. PubMed ID: 3492266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antitumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo.
    Schmidberger H; King L; Lasky LC; Vallera DA
    Cancer Res; 1990 Jun; 50(11):3249-56. PubMed ID: 1692258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancer.
    Epstein C; Lynch T; Shefner J; Wen P; Maxted D; Braman V; Ariniello P; Coral F; Ritz J
    Int J Cancer Suppl; 1994; 8():57-9. PubMed ID: 7515030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma.
    Griffin TW; Richardson C; Houston LL; LePage D; Bogden A; Raso V
    Cancer Res; 1987 Aug; 47(16):4266-70. PubMed ID: 3496960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rationale for clinical use of immunotoxins in cancer and autoimmune disease.
    Byers VS; Baldwin RW
    Semin Cell Biol; 1991 Feb; 2(1):59-70. PubMed ID: 1954344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice.
    Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R
    Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
    Antin JH; Bierer BE; Smith BR; Guinan EC; Provost MM; Ferrara J; Macklis RM; Tarbell NJ; Blythman H; Bouloux C
    Prog Clin Biol Res; 1990; 333():207-15. PubMed ID: 1689852
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates.
    Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW
    Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin.
    Kernan NA; Byers V; Scannon PJ; Mischak RP; Brochstein J; Flomenberg N; Dupont B; O'Reilly RJ
    JAMA; 1988 Jun; 259(21):3154-7. PubMed ID: 3285046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
    Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R
    Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
    Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
    Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rationale for immunotoxin therapy of metastatic prostate carcinoma formatted as a multi-stage delivery system.
    Webb KS; Poulton SH; Liberman SN; Walther PJ
    J Urol; 1989 Aug; 142(2 Pt 1):425-32. PubMed ID: 2787412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intratumour therapy of solid tumours with ricin-antibody conjugates.
    Kanellos J; McKenzie IF; Pietersz GA
    Immunol Cell Biol; 1989 Apr; 67 ( Pt 2)():89-99. PubMed ID: 2786496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Action of a CD24-specific deglycosylated ricin-A-chain immunotoxin in conventional and novel models of small-cell-lung-cancer xenograft.
    Zangemeister-Wittke U; Lehmann HP; Waibel R; Wawrzynczak EJ; Stahel RA
    Int J Cancer; 1993 Feb; 53(3):521-8. PubMed ID: 8381397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of the plasma clearance of antibody--ricin-A-chain immunotoxins. Evidence for specific recognition sites on the A chain that mediate rapid clearance of the immunotoxin.
    Bourrie BJ; Casellas P; Blythman HE; Jansen FK
    Eur J Biochem; 1986 Feb; 155(1):1-10. PubMed ID: 3948873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
    Ramakrishnan S; Bjorn MJ; Houston LL
    Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
    Calvete JA; Newell DR; Wright AF; Rose MS
    Cancer Res; 1994 Sep; 54(17):4684-90. PubMed ID: 8062265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.